Cavitation Technologies, Inc. (CVAT) — SEC Filings
Cavitation Technologies, Inc. (CVAT) — 9 SEC filings. Latest: 10-Q (Nov 13, 2025). Includes 6 10-Q, 2 10-K, 1 8-K.
View Cavitation Technologies, Inc. on SEC EDGAR
Overview
Cavitation Technologies, Inc. (CVAT) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 13, 2025: Cavitation Technologies, Inc. (CVAT) reported a net loss of $258,000 for the three months ended September 30, 2025, an increase from a net loss of $227,000 in the same period of 2024. Revenue significantly increased to $3,000 in Q3 2025 from $0 in Q3 2024, primarily from a short-term rental agreemen
Sentiment Summary
Across 9 filings, the sentiment breakdown is: 1 bullish, 2 bearish, 6 neutral. The dominant filing sentiment for Cavitation Technologies, Inc. is neutral.
Filing Type Overview
Cavitation Technologies, Inc. (CVAT) has filed 6 10-Q, 2 10-K, 1 8-K with the SEC between Feb 2024 to Nov 2025.
Filings by Year
Recent SEC Filings (9)
| Date | Form | Description | Risk |
|---|---|---|---|
| Nov 13, 2025 | 10-Q | Cavitation Technologies' Losses Widen Amid Cash Crunch | high |
| Sep 29, 2025 | 10-K | CVAT Pivots to Water, Alcohol Tech After Patent Sale | high |
| May 15, 2025 | 10-Q | Cavitation Technologies Files Q3 2025 10-Q | low |
| Feb 14, 2025 | 10-Q | Cavitation Technologies Files Q2 FY25 10-Q | low |
| Nov 14, 2024 | 10-Q | Cavitation Technologies Files 10-Q for Q3 2024 | medium |
| Sep 30, 2024 | 10-K | Cavitation Technologies Files 2024 10-K | low |
| Sep 16, 2024 | 8-K | Cavitation Technologies Announces Board Changes | medium |
| May 15, 2024 | 10-Q | Cavitation Technologies, Inc. Files 10-Q for Period Ending March 31, 2024 | medium |
| Feb 14, 2024 | 10-Q | Cavitation Technologies, Inc. Files 10-Q for Period Ending December 31, 2023 | medium |
Risk Profile
Risk Assessment: Of CVAT's 9 recent filings, 2 were flagged as high-risk, 4 as medium-risk, and 3 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $3,000 |
| Net Income | $ (258,000) |
| EPS | $ (0.00) |
| Debt-to-Equity | N/A |
| Cash Position | $30,000 |
| Operating Margin | N/A |
| Total Assets | $60,000 |
| Total Debt | $249,000 |
Key Executives
- Chief Executive Officer
- Roman Gordon
Industry Context
Cavitation Technologies operates in niche segments of the industrial processing market, including vegetable oil refining, renewable fuels, and water treatment. The company's proprietary Nano Reactor technology aims to offer cost and yield advantages over conventional methods. The market for advanced water treatment and sustainable fuel production is growing, but competitive pressures from established players and the need for significant capital investment for scaling remain key challenges.
Top Tags
10-Q (4) · financials (3) · Small Cap (2) · Water Treatment (2) · quarterly-filing (2) · agriculture-services (2) · Going Concern (1) · Net Loss (1) · Cash Burn (1) · Liquidity Risk (1)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Cash and cash equivalents | $30,000 | As of September 30, 2025, down from $249,000 at June 30, 2025 |
| Net loss | $258,000 | For the three months ended September 30, 2025, an increase from $227,000 in Q3 2024 |
| Revenue | $3,000 | For the three months ended September 30, 2025, up from $0 in Q3 2024 |
| Net cash used in operating activities | $219,000 | For the three months ended September 30, 2025 |
| Accumulated deficit | $27,218,000 | As of September 30, 2025 |
| Common stock outstanding | 289,156,340 | As of November 12, 2025 |
| Note payable - EIDL | $150,000 | Non-current liability as of September 30, 2025 |
| Interest rate | 3.75% | On the EIDL loan |
| Cash received from patent assignment to Desmet | $880,000 | Provided capital for continuous operations in October 2024 |
| Impairment charge on investment in Enviro WaterTek LLC | $1.1 million | Recorded in June 2023 due to insignificant operations |
| Shares of common stock outstanding | 289,156,340 | As of September 26, 2025 |
| Aggregate market value of common equity held by non-affiliates | $5,192,000 | As of December 31, 2024, based on $0.019 per share |
| Monthly advances from Desmet | $25,000 | Under February 2024 agreement, terminated in October 2024 |
| Outstanding advances waived by Desmet | $498,000 | Under October 2021 agreement, waived in February 2024 |
| Barrels of produced water per day (BPD) | 17,000 | Capacity of LPN system for Permian Basin water treatment |
Frequently Asked Questions
What are the latest SEC filings for Cavitation Technologies, Inc. (CVAT)?
Cavitation Technologies, Inc. has 9 recent SEC filings from Feb 2024 to Nov 2025, including 6 10-Q, 2 10-K, 1 8-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of CVAT filings?
Across 9 filings, the sentiment breakdown is: 1 bullish, 2 bearish, 6 neutral. The dominant sentiment is neutral.
Where can I find Cavitation Technologies, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Cavitation Technologies, Inc. (CVAT) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Cavitation Technologies, Inc.?
Key financial highlights from Cavitation Technologies, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for CVAT?
The investment thesis for CVAT includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Cavitation Technologies, Inc.?
Key executives identified across Cavitation Technologies, Inc.'s filings include Chief Executive Officer, Roman Gordon.
What are the main risk factors for Cavitation Technologies, Inc. stock?
Of CVAT's 9 assessed filings, 2 were flagged high-risk, 4 medium-risk, and 3 low-risk.
What are recent predictions and forward guidance from Cavitation Technologies, Inc.?
Forward guidance and predictions for Cavitation Technologies, Inc. are extracted from SEC filings as they are enriched.